Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

Autor: Turk Casey M, Fagan-Solis Katerina D, Williams Kristin E, Gozgit Joseph M, Smith-Schneider Sallie, Marconi Sharon A, Otis Christopher N, Crisi Giovanna M, Anderton Douglas L, Kilimann Manfred W, Arcaro Kathleen F
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Zdroj: Cancer Cell International, Vol 12, Iss 1, p 17 (2012)
Druh dokumentu: article
ISSN: 1475-2867
DOI: 10.1186/1475-2867-12-17
Popis: Abstract Background Paralemmin-1 is a phosphoprotein lipid-anchored to the cytoplasmic face of membranes where it functions in membrane dynamics, maintenance of cell shape, and process formation. Expression of paralemmin-1 and its major splice variant (Δ exon 8) as well as the extent of posttranslational modifications are tissue- and development-specific. Paralemmin-1 expression in normal breast and breast cancer tissue has not been described previously. Results Paralemmin-1 mRNA and protein expression was evaluated in ten breast cell lines, 26 primary tumors, and 10 reduction mammoplasty (RM) tissues using real time RT-PCR. Paralemmin-1 splice variants were assessed in tumor and RM tissues using a series of primers and RT-PCR. Paralemmin-1 protein expression was examined in cell lines using Western Blots and in 31 ductal carcinomas in situ, 65 infiltrating ductal carcinomas, and 40 RM tissues using immunohistochemistry. Paralemmin-1 mRNA levels were higher in breast cancers than in RM tissue and estrogen receptor (ER)-positive tumors had higher transcript levels than ER-negative tumors. The Δ exon 8 splice variant was detected more frequently in tumor than in RM tissues. Protein expression was consistent with mRNA results showing higher paralemmin-1 expression in ER-positive tumors. Conclusions The differential expression of paralemmin-1 in a subset of breast cancers suggests the existence of variation in membrane dynamics that may be exploited to improve diagnosis or provide a therapeutic target.
Databáze: Directory of Open Access Journals